177 437

Cited 27 times in

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

DC Field Value Language
dc.contributor.author김현창-
dc.contributor.author박성하-
dc.date.accessioned2020-02-11T06:04:28Z-
dc.date.available2020-02-11T06:04:28Z-
dc.date.issued2019-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/174523-
dc.description.abstractTreatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients' characteristics. Additionally, the target blood pressure or initial drug choice should be customized according to the special conditions of the hypertensive patients. In this part III, we reviewed previous data and presented recommendations for some special populations such as diabetes mellitus, chronic kidney disease, elderly people, and cardio-cerebrovascular disease.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherBiomed Central-
dc.relation.isPartOfClinical Hypertension-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.title2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Preventive Medicine and Public Health (예방의학교실)-
dc.contributor.googleauthorKwang-il Kim-
dc.contributor.googleauthorSang-Hyun Ihm-
dc.contributor.googleauthorGheun-Ho Kim-
dc.contributor.googleauthorHyeon Chang Kim-
dc.contributor.googleauthorJu Han Kim-
dc.contributor.googleauthorHae-Young Lee-
dc.contributor.googleauthorJang Hoon Lee-
dc.contributor.googleauthorJong-Moo Park-
dc.contributor.googleauthorSungha Park-
dc.contributor.googleauthorWook Bum Pyun-
dc.contributor.googleauthorJinho Shin-
dc.contributor.googleauthorShung Chull Chae-
dc.identifier.doi10.1186/s40885-019-0123-y-
dc.contributor.localIdA01142-
dc.contributor.localIdA01512-
dc.relation.journalcodeJ02982-
dc.identifier.eissn2056-5909-
dc.identifier.pmid31388452-
dc.subject.keywordAntihypertensive treatment-
dc.subject.keywordBlood pressure-
dc.subject.keywordCardiovascular complications-
dc.subject.keywordCardiovascular risk-
dc.subject.keywordGuidelines-
dc.subject.keywordHypertension-
dc.contributor.alternativeNameKim, Hyeon Chang-
dc.contributor.affiliatedAuthor김현창-
dc.contributor.affiliatedAuthor박성하-
dc.citation.volume25-
dc.citation.number1-
dc.citation.startPage19-
dc.identifier.bibliographicCitationClinical Hypertension, Vol.25(1) : 19, 2019-
dc.identifier.rimsid64869-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.